UPC sets infringement bar as Boehringer wins injunction against Zentiva
The UPC Court of Appeal granted Boehringer Ingelheim an injunction against Zentiva, ruling that completing regulatory steps — like pricing and reimbursement — can justify interim relief even before a generic...To view the full article, register now.
Already a subscriber? Click here to view full article